Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185185-17-002505
Filing Date
2017-11-28
Accepted
2017-11-28 21:01:12
Documents
1
Period of Report
2017-11-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form4-weild112817.html 4  
1 OWNERSHIP DOCUMENT form4-weild112817.xml 4 3094
  Complete submission text file 0001185185-17-002505.txt   4483
Mailing Address 12424 WILSHIRE BLVD. SUITE 745 LOS ANGELES CA 90025
Business Address 12424 WILSHIRE BLVD. SUITE 745 LOS ANGELES CA 90025 (310) 820-8100
BioSig Technologies, Inc. (Issuer) CIK: 0001530766 (see all company filings)

EIN.: 264333375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus

Mailing Address 22 ORIOLE AVENUE BRONXVILLE NY 10708
Business Address
Weild IV David (Reporting) CIK: 0001648023 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55473 | Film No.: 171226660